IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB)

CUSIP: 45674E109

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
9,783,925
Total 13F shares
286,664
Share change
-21,391,898
Total reported value
$599,128
Price per share
$2.09
Number of holders
1
Value change
-$19,546,322
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 45674E109?
CUSIP 45674E109 identifies INAB - IN8BIO, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of INAB - IN8BIO, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BIOS Capital Management, LP
13F
Company
88%
8,600,001
$1,427,600 31 Mar 2025
13F
Aaron G.l. Fletcher
3/4/5
10%+ Owner
mixed-class rows
11,825,804
mixed-class rows
$1,289,996 02 May 2025
Leslie W. Kreis
3/4/5
10%+ Owner
mixed-class rows
11,825,804
mixed-class rows
$1,289,996 02 May 2025
FRANKLIN RESOURCES INC
13F
Company
58%
5,696,202
$945,570 31 Mar 2025
13F
William Tai-Wei Ho
13D/G
3.7%
151,223
$349,325 $0 30 Jun 2025
Alyeska Investment Group, L.P.
13F 13D/G
Company
2.6%
from 13D/G
2,079,575
$345,209 31 Mar 2025
VANGUARD GROUP INC
13F
Company
18%
1,802,956
$299,291 31 Mar 2025
13F
Transcend Partners Opportunity Fund I LLC
13D/G
Transcend Partners Opportunity Fund LLC
2.6%
107,416
$248,131 $0 30 Jun 2025
AIGH Capital Management LLC
13F
Company
15%
1,450,000
$240,700 31 Mar 2025
13F
Sigma Planning Corp
13F
Company
7.2%
700,680
$116,313 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
5.8%
568,631
$94,403 31 Mar 2025
13F
Stonegate Investment Group, LLC
13F
Company
1.8%
180,000
$29,880 31 Mar 2025
13F
Orin Hirschman
13D/G
4.4%
149,895
$17,987 -$725,036 30 Jun 2025
NORTHERN TRUST CORP
13F
Company
0.95%
93,420
$15,508 31 Mar 2025
13F
STATE STREET CORP
13F
Company
0.91%
88,746
$14,732 31 Mar 2025
13F
XTX Topco Ltd
13F
Company
0.71%
69,708
$11,572 31 Mar 2025
13F
Chicago Partners Investment Group LLC
13F
Company
0.71%
69,301
$11,400 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
0.6%
58,504
$9,712 31 Mar 2025
13F
Trishna Goswami
3/4/5
Chief Medical Officer
mixed-class rows
440,925
mixed-class rows
$6,931 04 Sep 2024
TWO SIGMA SECURITIES, LLC
13F
Company
0.35%
34,279
$5,690 31 Mar 2025
13F
Overbrook Management Corp
13F
Company
0.35%
33,756
$5,604 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.3%
29,450
$4,889 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.25%
24,812
$4,119 31 Mar 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.21%
20,292
$3,368 31 Mar 2025
13F
Virtu Financial LLC
13F
Company
0.15%
15,110
$3,000 31 Mar 2025
13F
Capital Investment Advisory Services, LLC
13F
Company
0.18%
17,605
$2,922 31 Mar 2025
13F
UBS Group AG
13F
Company
0.13%
12,327
$2,046 31 Mar 2025
13F
LPL Financial LLC
13F
Company
0.12%
11,350
$1,884 31 Mar 2025
13F
HighTower Advisors, LLC
13F
Company
0.1%
10,000
$1,660 31 Mar 2025
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0.08%
8,263
$1,372 31 Mar 2025
13F
Westside Investment Management, Inc.
13F
Company
0.02%
2,000
$332 31 Mar 2025
13F
SBI Securities Co., Ltd.
13F
Company
0.01%
1,007
$167 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
485
$81 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0%
102
$17 31 Mar 2025
13F
Travis Whitfill
3/4/5
Director
class O/S missing
42,676
19 Dec 2024

Institutional Holders of IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) as of Q2 2025

As of 30 Jun 2025, IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 286,664 shares. The largest 1 holders included BIOS Capital Management, LP. This page lists 1 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
28
Q2 2025 holders
1
Holder diff
-27
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .